Free Trial

AXQ Capital LP Purchases Shares of 13,767 Marsh & McLennan Companies, Inc. $MRSH

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • AXQ Capital LP initiated a new position in Marsh & McLennan Companies, buying 13,767 shares worth about $2.55 million. The stake is now its 9th largest holding and represents 0.6% of the portfolio.
  • Institutional ownership remains very high, with 87.99% of the stock held by institutional investors. Several large firms, including Vanguard and Wellington Management, also added to their positions recently.
  • Analysts are cautious overall: Marsh & McLennan has a consensus Hold rating and an average price target of $203.56, after several firms trimmed targets in recent notes. CEO John Q. Doyle also sold 16,655 shares in March.
  • Five stocks we like better than Marsh & McLennan Companies.

AXQ Capital LP bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 13,767 shares of the financial services provider's stock, valued at approximately $2,554,000. Marsh & McLennan Companies makes up 0.6% of AXQ Capital LP's investment portfolio, making the stock its 9th largest holding.

A number of other large investors also recently modified their holdings of MRSH. Vanguard Group Inc. raised its position in Marsh & McLennan Companies by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 46,589,633 shares of the financial services provider's stock valued at $8,643,309,000 after buying an additional 387,100 shares during the last quarter. State Street Corp grew its stake in Marsh & McLennan Companies by 0.4% in the 3rd quarter. State Street Corp now owns 21,538,014 shares of the financial services provider's stock valued at $4,340,556,000 after purchasing an additional 96,436 shares during the period. Capital International Investors grew its stake in Marsh & McLennan Companies by 1.2% in the 3rd quarter. Capital International Investors now owns 18,590,697 shares of the financial services provider's stock valued at $3,745,889,000 after purchasing an additional 221,033 shares during the period. Capital World Investors grew its stake in Marsh & McLennan Companies by 0.5% in the 3rd quarter. Capital World Investors now owns 17,702,898 shares of the financial services provider's stock valued at $3,567,410,000 after purchasing an additional 92,767 shares during the period. Finally, Wellington Management Group LLP grew its stake in Marsh & McLennan Companies by 9.1% in the 3rd quarter. Wellington Management Group LLP now owns 15,091,478 shares of the financial services provider's stock valued at $3,041,386,000 after purchasing an additional 1,260,434 shares during the period. 87.99% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Weiss Ratings downgraded Marsh & McLennan Companies from a "hold (c)" rating to a "hold (c-)" rating in a research note on Monday, May 11th. JPMorgan Chase & Co. cut their price target on Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating for the company in a research note on Thursday, April 9th. Morgan Stanley cut their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an "equal weight" rating for the company in a research note on Monday, April 6th. Piper Sandler cut their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating for the company in a research note on Tuesday, May 26th. Finally, Mizuho cut their price target on Marsh & McLennan Companies from $199.00 to $193.00 and set a "neutral" rating for the company in a research note on Monday, April 13th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Marsh & McLennan Companies currently has a consensus rating of "Hold" and a consensus price target of $203.56.

Read Our Latest Report on MRSH

Insider Buying and Selling at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,655 shares of the firm's stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $21,411,456.30. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.38% of the company's stock.

Marsh & McLennan Companies Stock Performance

NYSE:MRSH opened at $162.44 on Tuesday. The business's 50-day moving average price is $164.41 and its two-hundred day moving average price is $171.56. Marsh & McLennan Companies, Inc. has a twelve month low of $157.74 and a twelve month high of $235.78. The stock has a market cap of $78.47 billion, a P/E ratio of 20.30, a PEG ratio of 2.33 and a beta of 0.62. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating analysts' consensus estimates of $3.21 by $0.08. The company had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.Marsh & McLennan Companies's revenue for the quarter was up 7.6% on a year-over-year basis. As a group, equities analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Recommended Stories

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines